Why should I choose Ageless over an hormonal diet, pill or pellet program?
We put our patients’ long-term health and safety above all else, and our medical professionals do not endorse weight loss methods that can be dangerous and/or deceptive. Don’t just take our word for it, see what other leading medical experts have to say:
Thousands of people are latching onto a diet that promises rapid weight loss—up to 30 pounds a month—and, judging by its recent surge in popularity, actually delivers. But the so-called hormonal diet is either a weight-loss miracle or a dangerous fraud, depending on who’s talking. The plan combines drops or injections of hormonal diet, a pregnancy hormone, with just 500 calories a day. While some believers are so convinced of its power they’ll willingly stick themselves with a syringe, the government and mainstream medical community say it’s a scam that carries too many health risks and doesn’t lead to long-term weight loss.
“It’s reckless, irresponsible, and completely irrational,” says Pieter Cohen, an assistant professor of medicine at Harvard Medical School. “Can you lose weight on it? Of course, but that’s mainly because you’re hardly consuming any calories. And any benefit is not going to last.”
“This year, I’m going to lose some weight.” If you find yourself making this common New Year’s resolution, know this: many so-called “miracle” weight loss supplements and foods (including teas and coffees) don’t live up to their claims. Worse, they can cause serious harm, say FDA regulators. The agency has found hundreds of products that are marketed as dietary supplements but actually contain hidden active ingredients (components that make a medicine effective against a specific illness) contained in prescription drugs, unsafe ingredients that were in drugs that have been removed from the market, or compounds that have not been adequately studied in humans.
“When the product contains a drug or other ingredient which is not listed as an ingredient we become especially concerned about the safety of the product,” says James P. Smith, M.D., an acting deputy director in FDA’s Office of Drug Evaluation.